Selective Ghrelin-receptor agonist studied for growth hormone release specifically for muscle preservation, recovery, and sleep quality with reportedly fewer effects on cortisol/prolactin than older secretagogues; not FDA-approved, limited controlled human data.
Selective Ghrelin-receptor agonist studied for growth hormone release specifically for muscle preservation, recovery, and sleep quality with reportedly fewer effects on cortisol/prolactin than older secretagogues; not FDA-approved, limited controlled human data.
| Concentration | Injectable: 2 mg/mL; Nasal (w/CJC-1295): 0.15/0.15 mg; Sublingual (w/CJC-1295): 0.5/0.5 mg |
|---|---|
| Volume | Injectable: 5 mL |
| Total mg/Vial | Injectable: 10 mg |
